Nitric Acid

Nitric Acid

SCHEMBL4527995

CC1(C)N=C(c2cnc3ccccc3c2)c2cccc(F)c2C1(C)C.O=[N+]([O-])O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
AKR1C3 P42330 2/20 0.41
AKR1C2 P52895 2/20 0.41
MAP4K4 O95819 1/20 0.39
CSNK1G2 P78368 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
MAP4K5 Q9Y4K4 1/20 0.39
TRPV3 Q8NET8 1/20 0.37
BRD4 O60885 2/20 0.36
CREBBP Q92793 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
FASN P49327 2/20 0.35
SLC22A12 Q96S37 1/20 0.35
BIRC5 O15392 1/20 0.35
NR2F2 P24468 1/20 0.35
PDGFRB P09619 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL318061 0.91 AKR1C3 (0.41) AKR1C3AKR1C2MAP4K4CSNK1G2CLK4
SCHEMBL29352004 0.91 AKR1C3 (0.41) AKR1C3AKR1C2MAP4K4CSNK1G2CLK4
Hydrochloric Acid SCHEMBL4531372 0.90 AKR1C3 (0.41) AKR1C3AKR1C2MAP4K4CSNK1G2CLK4
Sulfuric Acid SCHEMBL4533948 0.89 AKR1C3 (0.42) AKR1C3AKR1C2MAP4K4CSNK1G2CLK4
SCHEMBL4518807 0.88 AKR1C3 (0.41) AKR1C3AKR1C2MAP4K4CSNK1G2CLK4
SCHEMBL20521243 0.84 AKR1C3 (0.37) AKR1C3AKR1C2MAP4K4CSNK1G2CLK4
SCHEMBL322332 0.83 AKR1C3 (0.43) AKR1C3AKR1C2MAP4K4CSNK1G2CLK4
SCHEMBL29353222 0.83 AKR1C3 (0.43) AKR1C3AKR1C2MAP4K4CSNK1G2CLK4
Nitric Acid SCHEMBL4521661 0.83 AKR1C3 (0.42) ALDH1A1AKR1C3AKR1C2MAP4K4CSNK1G2
SCHEMBL4507256 0.82 L3MBTL1 (0.39) AKR1C3AKR1C2TRPV3PDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1736471-B1 3-(DIHYDRO(TETRAHYDRO)ISOQUINOLIN-1-YL)QUINOLINES MITSUI CHEMICALS AGRO INC (JP) 2014-01-08 EP disclosed
US-7632783-B2 fungicides, pesticides for protecting rice crop, tomatoes, cucumbers and green beans; 3-(5-fluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline MITSUI CHEMICALS AGRO, INC. (JP) 2009-12-15 US disclosed
CN-100556904-C 3- (dihydro (tetrahydro) isoquinolin-1-yl) quinoline compounds SANKYO AGRO CO LTD (JP) 2009-11-04 CN disclosed
US-20080275242-A1 3-(Dihydro(Tetrahydro)Isoquinolin-1-Yl)Quinoline Compound MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) 2008-11-06 US disclosed
CN-1910172-A 3- (dihydro (tetrahydro) isoquinolin-1-yl) quinoline compounds SANKYO AGRO CO LTD (JP) 2007-02-07 CN disclosed
EP-1736471-A1 3-(DIHYDRO(TETRAHYDRO)ISOQUINOLIN-1-YL)QUINOLINES Sankyo Agro Company, Limited (JP) 2006-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275242-A1 3-(Dihydro(Tetrahydro)Isoquinolin-1-Yl)Quinoline Compound QTRT1, RABL3, RECQL ALDH1A1 1185/4885AKR1C3 1232/4885AKR1C2 1859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.